Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases

Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases

Stereotactic ablative radiotherapy (SABR) planning for adrenal metastases aims to minimize doses to the adjacent kidney. Renal dose constraints for SABR delivery are not well defined. In 20 patients who underwent MR-guided breath-hold SABR in five daily fractions of 8–10 Gy, ipsilateral renal volume...

Full description

Bibliographic Details
Main Authors:	John R. van Sörnsen de Koste, Claire C. van Vliet, Famke L. Schneiders, Anna M.E. Bruynzeel, Berend J. Slotman, Miguel A. Palacios, Suresh Senan
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	Physics and Imaging in Radiation Oncology
Subjects:	SABR Adrenal Kidney Organ at Risk Renal dose constraints
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405631621000518

Similar Items

Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk
by: Famke L. Schneiders, et al.
Published: (2023-11-01)

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy
by: Tobias Finazzi, et al.
Published: (2020-04-01)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01)

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
by: Shankar Siva, et al.
Published: (2018-10-01)

Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases
by: Gamze Ugurluer, et al.
Published: (2024-05-01)

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort
by: D. Doppenberg, et al.
Published: (2023-05-01)

Uncovering the armpit of SBRT: An institutional experience with stereotactic radiation of axillary metastases
by: A. Mutsaers, et al.
Published: (2024-03-01)

Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
by: Philipp Hoegen, et al.
Published: (2023-03-01)

First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer
by: Anjali Zarkar, et al.
Published: (2023-07-01)

Precision of image-guided spinal stereotactic ablative radiotherapy and impact of positioning variables
by: Charlotte Billiet, et al.
Published: (2022-04-01)

The sabre of Ibrahim Pasha, the Kaffa serasker, as a relic of the Russo-Turkish War (1768-1775)
by: Dr. Vasiliy R. Novoselov
Published: (2024-02-01)

Same-day consultation, simulation and lung Stereotactic Ablative Radiotherapy delivery on a Magnetic Resonance-linac
by: Miguel A. Palacios, et al.
Published: (2022-10-01)

Stereotactic radiotherapy: An educational narrative review
by: Agha Muhammad Hammad Khan, et al.
Published: (2024-03-01)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
by: Cyrielle Scouarnec, et al.
Published: (2019-08-01)

NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy
by: Nicholas Hardcastle, et al.
Published: (2019-09-01)

Stereotactic body radiation therapy in the treatment of ovarian cancer
by: Roman O. Kowalchuk, et al.
Published: (2020-05-01)

Stereotactic Body Radiotherapy (SBRT) in Very Limited-Stage Small Cell Lung Cancer (VLS-SCLC)
by: Stéphanie L. Mercier, et al.
Published: (2022-12-01)

A Valuable Book Collection of SABRE-Zagreb Donated to the Zagreb Natural Sciences Faculty
by: Valenta, A.
Published: (2010-06-01)

A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer
by: Slotman Ben J, et al.
Published: (2006-03-01)

A strategy to reduce fraction number in peripheral lung stereotactic ablative body radiotherapy
by: Serena O'Keeffe, et al.
Published: (2023-04-01)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
by: Rodney E. Wegner, et al.
Published: (2019-05-01)

Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy
by: E. Leung, et al.
Published: (2020-01-01)

Stereotactic Body Therapy for Urologic Cancers—What the Urologist Needs to Know
by: Jasamine Coles-Black, et al.
Published: (2024-12-01)

The potential of integrating stereotactic ablative radiotherapy techniques with hyperfractionation for lung cancer
by: Chi‐Chuan Chiou, et al.
Published: (2024-08-01)

Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
by: D. Doppenberg, et al.
Published: (2022-12-01)

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer
by: Dan Yang, et al.
Published: (2020-03-01)

Hypofractionated image-guided breath-hold SABR (Stereotactic Ablative Body Radiotherapy) of liver metastases – clinical results
by: Boda-Heggemann Judit, et al.
Published: (2012-06-01)

Stereotactic Body Radiotherapy Immunological Planning—A Review With a Proposed Theoretical Model
by: Kumara Swamy
Published: (2022-01-01)

Stereotactic ablative radiotherapy as single treatment for early stage non‐small cell lung cancer: A single institution analysis
by: Xiaoli Zheng, et al.
Published: (2021-03-01)

Outcome of lung oligometastatic patients treated with stereotactic body irradiation
by: Guillaume Virbel, et al.
Published: (2022-07-01)

Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis
by: C. Yuste, et al.
Published: (2024-03-01)

Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases
by: Matthew Mills, et al.
Published: (2024-03-01)

A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer
by: Anurag K. Singh, et al.
Published: (2018-11-01)

Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases – Which patients do really benefit from an MR-linac?
by: Philipp Hoegen-Saßmannshausen, et al.
Published: (2025-05-01)

Adrenal abscess as a complication of neonatal adrenal hemorrhage
by: Alexandre Henrard, et al.
Published: (2022-08-01)

Stereotactic ablative body radiation therapy for isolated pulmonary metastases from pancreatic cancer after metastectomy with positive margins: a case report
by: Anoud Alnsour, et al.
Published: (2023-06-01)

Renal cell carcinoma with ipsilateral adrenal involvement with synchronous contralateral adrenal metastases
by: Rajan Sharma, et al.
Published: (2006-01-01)

Extension of SABR Libor Market Model to handle negative interest rates
by: Jie Xiong, et al.
Published: (2020-03-01)

SABRE in Croatia - The New, 57th Shipment of Books
by: Pavić, H., et al.
Published: (2011-12-01)

Case Report: Hematologic Recovery Following Stereotactic Ablative Radiotherapy in a Patient With Early-Stage Non-Small Cell Lung Cancer and Paraneoplastic Myelofibrosis
by: Lindsey Sloan, et al.
Published: (2022-02-01)